A Prospective Study to Optimize Insulin Treatment by Basal Regimen With Insulin Glargine in Type-2-Diabetic Patients Previously Uncontrolled on Premixed Insulin
Phase of Trial: Phase IV
Latest Information Update: 23 Apr 2013
At a glance
- Drugs Insulin glargine (Primary)
- Indications Type 2 diabetes mellitus
- Focus Therapeutic Use
- Acronyms OPTIMIZATION
- Sponsors Sanofi
- 31 Aug 2018 Biomarkers information updated
- 12 Aug 2009 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
- 12 Aug 2009 Actual patient number (313) added as reported by ClinicalTrials.gov.